Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radionuclide Imaging | 7 | 2023 | 2031 | 1.850 |
Why?
|
Neuroblastoma | 14 | 2023 | 1226 | 1.670 |
Why?
|
Hodgkin Disease | 10 | 2023 | 1415 | 1.590 |
Why?
|
Osteoma, Osteoid | 2 | 2023 | 80 | 1.330 |
Why?
|
Radiopharmaceuticals | 10 | 2022 | 2645 | 1.230 |
Why?
|
Paraganglioma | 3 | 2022 | 143 | 1.060 |
Why?
|
Bone Neoplasms | 8 | 2023 | 2529 | 1.010 |
Why?
|
Oropharynx | 2 | 2020 | 127 | 0.880 |
Why?
|
Gastric Emptying | 2 | 2022 | 233 | 0.840 |
Why?
|
Pheochromocytoma | 2 | 2022 | 337 | 0.830 |
Why?
|
Radioisotope Renography | 1 | 2022 | 62 | 0.830 |
Why?
|
3-Iodobenzylguanidine | 3 | 2023 | 115 | 0.820 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2022 | 740 | 0.800 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2020 | 47 | 0.750 |
Why?
|
Population Surveillance | 3 | 2019 | 2616 | 0.740 |
Why?
|
Hepatoblastoma | 3 | 2018 | 87 | 0.740 |
Why?
|
Positron-Emission Tomography | 13 | 2023 | 6234 | 0.710 |
Why?
|
Embolic Protection Devices | 1 | 2019 | 42 | 0.670 |
Why?
|
Neck Injuries | 1 | 2020 | 152 | 0.670 |
Why?
|
Child | 62 | 2024 | 77709 | 0.650 |
Why?
|
Spinal Neoplasms | 2 | 2023 | 760 | 0.610 |
Why?
|
Intracranial Embolism | 1 | 2019 | 202 | 0.600 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2017 | 136 | 0.580 |
Why?
|
Sternotomy | 1 | 2018 | 121 | 0.580 |
Why?
|
Receptors, Interleukin-2 | 10 | 2010 | 573 | 0.580 |
Why?
|
Postural Balance | 1 | 2021 | 620 | 0.570 |
Why?
|
Surgical Wound Dehiscence | 1 | 2018 | 215 | 0.570 |
Why?
|
Foreign Bodies | 1 | 2020 | 399 | 0.540 |
Why?
|
Neoplasms | 18 | 2024 | 21683 | 0.530 |
Why?
|
Wilms Tumor | 1 | 2018 | 373 | 0.520 |
Why?
|
Interleukin-2 | 13 | 2010 | 1904 | 0.520 |
Why?
|
Bone Plates | 1 | 2018 | 468 | 0.500 |
Why?
|
Gait | 1 | 2020 | 793 | 0.490 |
Why?
|
Tomography, X-Ray Computed | 11 | 2023 | 20129 | 0.470 |
Why?
|
Growth Plate | 1 | 2014 | 274 | 0.430 |
Why?
|
Chest Tubes | 1 | 2013 | 150 | 0.430 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2019 | 1381 | 0.420 |
Why?
|
Radiometry | 1 | 2017 | 800 | 0.410 |
Why?
|
Adolescent | 46 | 2024 | 85781 | 0.400 |
Why?
|
Diagnostic Imaging | 9 | 2019 | 3507 | 0.400 |
Why?
|
Neoplasm Staging | 14 | 2020 | 11031 | 0.400 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 401 | 0.400 |
Why?
|
Child, Preschool | 33 | 2021 | 41006 | 0.390 |
Why?
|
Kidney Diseases | 1 | 2022 | 2149 | 0.370 |
Why?
|
Aortic Valve Stenosis | 2 | 2022 | 1965 | 0.370 |
Why?
|
Magnetic Resonance Imaging | 17 | 2023 | 35421 | 0.370 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 1488 | 0.370 |
Why?
|
Liver Neoplasms | 5 | 2020 | 4253 | 0.360 |
Why?
|
Granuloma, Plasma Cell | 2 | 2022 | 84 | 0.360 |
Why?
|
Aortic Valve | 2 | 2022 | 1922 | 0.360 |
Why?
|
Medical Oncology | 3 | 2022 | 2265 | 0.350 |
Why?
|
Body Burden | 1 | 2009 | 158 | 0.340 |
Why?
|
Reference Values | 3 | 2021 | 4982 | 0.340 |
Why?
|
Sarcoma, Synovial | 1 | 2010 | 167 | 0.340 |
Why?
|
Databases, Factual | 3 | 2021 | 7729 | 0.330 |
Why?
|
Fatty Liver | 3 | 2013 | 727 | 0.320 |
Why?
|
Fluorodeoxyglucose F18 | 6 | 2023 | 2016 | 0.320 |
Why?
|
Humans | 116 | 2024 | 744343 | 0.310 |
Why?
|
Immunoconjugates | 3 | 2015 | 901 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2019 | 5172 | 0.300 |
Why?
|
Drainage | 1 | 2013 | 1142 | 0.300 |
Why?
|
Radiation Protection | 2 | 2017 | 419 | 0.300 |
Why?
|
Tibia | 1 | 2013 | 1077 | 0.300 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2007 | 88 | 0.300 |
Why?
|
Bronchial Neoplasms | 1 | 2007 | 112 | 0.290 |
Why?
|
Copper Radioisotopes | 3 | 2015 | 86 | 0.290 |
Why?
|
Pediatrics | 3 | 2011 | 3475 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2024 | 9239 | 0.290 |
Why?
|
Wound Healing | 1 | 2018 | 2785 | 0.290 |
Why?
|
Radiography, Thoracic | 1 | 2013 | 1265 | 0.290 |
Why?
|
Thoracic Surgery | 1 | 2013 | 719 | 0.290 |
Why?
|
Contrast Media | 5 | 2019 | 5300 | 0.280 |
Why?
|
Bronchopulmonary Sequestration | 1 | 2006 | 42 | 0.280 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4042 | 0.270 |
Why?
|
Fluorescent Dyes | 1 | 2014 | 1917 | 0.270 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 11 | 2023 | 11524 | 0.260 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2038 | 0.260 |
Why?
|
Killer Cells, Natural | 6 | 1998 | 2133 | 0.250 |
Why?
|
Tomography, Emission-Computed | 1 | 2007 | 1144 | 0.240 |
Why?
|
Female | 58 | 2023 | 380194 | 0.240 |
Why?
|
Male | 50 | 2023 | 350118 | 0.240 |
Why?
|
Central Nervous System Neoplasms | 3 | 2024 | 895 | 0.240 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2635 | 0.240 |
Why?
|
Aniline Compounds | 2 | 2010 | 986 | 0.230 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 2 | 2017 | 169 | 0.230 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2013 | 1378 | 0.220 |
Why?
|
Neurofibromatoses | 2 | 2017 | 299 | 0.220 |
Why?
|
Minors | 1 | 2023 | 50 | 0.220 |
Why?
|
Lipodystrophy | 1 | 2024 | 147 | 0.220 |
Why?
|
Young Adult | 18 | 2023 | 56430 | 0.220 |
Why?
|
Retrospective Studies | 18 | 2023 | 77449 | 0.210 |
Why?
|
Technetium Tc 99m Mertiatide | 1 | 2022 | 22 | 0.210 |
Why?
|
Gadolinium | 2 | 2017 | 952 | 0.210 |
Why?
|
Kidney Neoplasms | 2 | 2018 | 4262 | 0.210 |
Why?
|
Infant | 21 | 2023 | 35136 | 0.200 |
Why?
|
Surface Plasmon Resonance | 1 | 2022 | 274 | 0.200 |
Why?
|
Glomus Tumor | 1 | 2022 | 66 | 0.200 |
Why?
|
Neurilemmoma | 2 | 2017 | 547 | 0.200 |
Why?
|
Antibodies, Monoclonal | 12 | 2024 | 9274 | 0.200 |
Why?
|
Dairy Products | 1 | 2005 | 498 | 0.200 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2024 | 255 | 0.200 |
Why?
|
Severe Combined Immunodeficiency | 5 | 1998 | 223 | 0.190 |
Why?
|
Indenes | 1 | 2021 | 57 | 0.190 |
Why?
|
Phantoms, Imaging | 3 | 2023 | 2480 | 0.190 |
Why?
|
Cheese | 1 | 2020 | 38 | 0.190 |
Why?
|
Polycythemia | 1 | 2021 | 126 | 0.190 |
Why?
|
Plasmacytoma | 1 | 2001 | 183 | 0.190 |
Why?
|
Pyridines | 3 | 2018 | 2825 | 0.180 |
Why?
|
Maximum Tolerated Dose | 6 | 2024 | 892 | 0.180 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2013 | 2737 | 0.180 |
Why?
|
Polyneuropathies | 1 | 2001 | 137 | 0.180 |
Why?
|
Lymphocyte Activation | 11 | 1998 | 5524 | 0.180 |
Why?
|
Yoga | 1 | 2023 | 253 | 0.180 |
Why?
|
Luminescent Proteins | 1 | 2002 | 853 | 0.170 |
Why?
|
Eggs | 1 | 2020 | 184 | 0.170 |
Why?
|
Alkaline Phosphatase | 1 | 2002 | 865 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 5 | 2022 | 5535 | 0.170 |
Why?
|
Lipids | 2 | 2013 | 3305 | 0.170 |
Why?
|
Water | 1 | 2005 | 1395 | 0.170 |
Why?
|
Salvage Therapy | 2 | 2018 | 1275 | 0.160 |
Why?
|
Leukemia | 3 | 2019 | 1511 | 0.160 |
Why?
|
Biliary Tract Diseases | 1 | 1999 | 161 | 0.160 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2022 | 584 | 0.160 |
Why?
|
Receptors, Mitogen | 1 | 1998 | 62 | 0.160 |
Why?
|
Radiation Dosage | 3 | 2023 | 1928 | 0.160 |
Why?
|
Fibroblast Growth Factors | 1 | 2024 | 879 | 0.160 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2023 | 1107 | 0.150 |
Why?
|
Lectins, C-Type | 2 | 1998 | 588 | 0.150 |
Why?
|
Optic Nerve Glioma | 1 | 2017 | 32 | 0.150 |
Why?
|
Breast | 1 | 2006 | 1969 | 0.150 |
Why?
|
Pyrazoles | 3 | 2019 | 1972 | 0.150 |
Why?
|
Pancreatic Diseases | 1 | 1999 | 350 | 0.150 |
Why?
|
Fanconi Syndrome | 1 | 2017 | 35 | 0.150 |
Why?
|
Neoplasm, Residual | 2 | 2020 | 973 | 0.150 |
Why?
|
Radiation, Ionizing | 1 | 2017 | 258 | 0.140 |
Why?
|
Sarcoma | 2 | 2022 | 1897 | 0.140 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2017 | 83 | 0.140 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2017 | 114 | 0.140 |
Why?
|
Azepines | 1 | 2019 | 336 | 0.140 |
Why?
|
Foot | 1 | 2020 | 527 | 0.140 |
Why?
|
Amyloid | 1 | 2001 | 795 | 0.140 |
Why?
|
Ischemic Attack, Transient | 1 | 2022 | 935 | 0.140 |
Why?
|
Lipectomy | 1 | 2017 | 118 | 0.140 |
Why?
|
von Hippel-Lindau Disease | 1 | 2017 | 152 | 0.140 |
Why?
|
Parotid Neoplasms | 1 | 2017 | 155 | 0.140 |
Why?
|
Melanoma | 4 | 2010 | 5510 | 0.130 |
Why?
|
Prognosis | 8 | 2018 | 29063 | 0.130 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2022 | 1660 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.130 |
Why?
|
Food | 1 | 2020 | 771 | 0.130 |
Why?
|
Genetic Vectors | 2 | 2002 | 3420 | 0.130 |
Why?
|
Titanium | 1 | 2018 | 494 | 0.130 |
Why?
|
Anilides | 1 | 2018 | 408 | 0.130 |
Why?
|
Diagnosis, Differential | 6 | 2013 | 12959 | 0.130 |
Why?
|
Whole Body Imaging | 1 | 2017 | 280 | 0.130 |
Why?
|
Antineoplastic Agents | 6 | 2019 | 13695 | 0.130 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5442 | 0.130 |
Why?
|
Recombinant Fusion Proteins | 2 | 2002 | 3772 | 0.120 |
Why?
|
Pyrimidines | 2 | 2019 | 2942 | 0.120 |
Why?
|
Affinity Labels | 1 | 2014 | 109 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2022 | 2455 | 0.120 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2014 | 143 | 0.120 |
Why?
|
Antigens, CD | 5 | 1998 | 4026 | 0.120 |
Why?
|
Follow-Up Studies | 8 | 2017 | 39050 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2017 | 8949 | 0.110 |
Why?
|
Iodine Radioisotopes | 1 | 2017 | 1032 | 0.110 |
Why?
|
Rhodamines | 1 | 2014 | 183 | 0.110 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2014 | 195 | 0.110 |
Why?
|
Chelating Agents | 2 | 2015 | 380 | 0.110 |
Why?
|
Molecular Probes | 1 | 2015 | 316 | 0.110 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1888 | 0.110 |
Why?
|
Lymphoproliferative Disorders | 1 | 2016 | 523 | 0.110 |
Why?
|
Soybean Oil | 1 | 2013 | 133 | 0.110 |
Why?
|
Hemangioma | 1 | 2017 | 738 | 0.100 |
Why?
|
Neurofibromatosis 1 | 1 | 2017 | 569 | 0.100 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2017 | 736 | 0.100 |
Why?
|
Time Factors | 7 | 2022 | 40075 | 0.100 |
Why?
|
Prenatal Diagnosis | 2 | 2009 | 1236 | 0.100 |
Why?
|
Cohort Studies | 5 | 2018 | 40561 | 0.100 |
Why?
|
Liver Diseases | 1 | 1999 | 1253 | 0.100 |
Why?
|
Receptor, IGF Type 1 | 1 | 2013 | 390 | 0.100 |
Why?
|
Treatment Outcome | 13 | 2022 | 63114 | 0.100 |
Why?
|
Homeostasis | 1 | 2022 | 3340 | 0.090 |
Why?
|
Lymphedema | 1 | 2017 | 534 | 0.090 |
Why?
|
Adult | 17 | 2024 | 214055 | 0.090 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 4838 | 0.090 |
Why?
|
Diet, Fat-Restricted | 1 | 2013 | 320 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1620 | 0.090 |
Why?
|
Transcription Factors | 2 | 2017 | 12208 | 0.090 |
Why?
|
Cholestasis | 1 | 2013 | 378 | 0.090 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2013 | 321 | 0.090 |
Why?
|
Membrane Glycoproteins | 2 | 1998 | 3768 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 570 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2002 | 5097 | 0.090 |
Why?
|
Fish Oils | 1 | 2013 | 470 | 0.090 |
Why?
|
Intestinal Atresia | 1 | 2009 | 68 | 0.090 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2011 | 162 | 0.090 |
Why?
|
Pylorus | 1 | 2009 | 86 | 0.090 |
Why?
|
Thyroid Nodule | 1 | 2016 | 750 | 0.080 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1990 | 906 | 0.080 |
Why?
|
Thymus Neoplasms | 3 | 2005 | 268 | 0.080 |
Why?
|
Disease-Free Survival | 5 | 2023 | 6895 | 0.080 |
Why?
|
Hemodynamics | 1 | 2019 | 4199 | 0.080 |
Why?
|
Tumor Cells, Cultured | 6 | 2002 | 6314 | 0.080 |
Why?
|
Small Molecule Libraries | 1 | 2014 | 720 | 0.080 |
Why?
|
Neoplasm Transplantation | 2 | 2015 | 2085 | 0.080 |
Why?
|
Keratins | 1 | 2010 | 515 | 0.080 |
Why?
|
Meningioma | 1 | 2017 | 1209 | 0.080 |
Why?
|
Kidney | 2 | 2022 | 7186 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3462 | 0.080 |
Why?
|
Pain Measurement | 1 | 2018 | 3420 | 0.080 |
Why?
|
Asparaginase | 1 | 2009 | 236 | 0.080 |
Why?
|
Relative Biological Effectiveness | 1 | 2009 | 323 | 0.080 |
Why?
|
Liver | 3 | 2020 | 7474 | 0.080 |
Why?
|
Skin Neoplasms | 2 | 2017 | 5686 | 0.080 |
Why?
|
Recurrence | 3 | 2019 | 8340 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2017 | 25625 | 0.080 |
Why?
|
Diseases in Twins | 1 | 2009 | 449 | 0.080 |
Why?
|
Cross-Linking Reagents | 1 | 2010 | 694 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
Pubic Symphysis Diastasis | 1 | 2006 | 2 | 0.070 |
Why?
|
Artifacts | 2 | 2013 | 1904 | 0.070 |
Why?
|
Musculoskeletal Diseases | 1 | 2013 | 581 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 3 | 2012 | 6538 | 0.070 |
Why?
|
Pubic Symphysis | 1 | 2006 | 21 | 0.070 |
Why?
|
Lymphoma | 3 | 2011 | 1877 | 0.070 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 1998 | 189 | 0.070 |
Why?
|
Early Detection of Cancer | 2 | 2017 | 3086 | 0.070 |
Why?
|
Patient Care Team | 1 | 2017 | 2531 | 0.070 |
Why?
|
Pattern Recognition, Automated | 1 | 2013 | 1005 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2023 | 2124 | 0.070 |
Why?
|
Anesthesia | 1 | 2017 | 1561 | 0.070 |
Why?
|
Abdomen | 1 | 2012 | 1118 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2022 | 16689 | 0.070 |
Why?
|
Algorithms | 5 | 2013 | 13881 | 0.070 |
Why?
|
Diffusion | 3 | 2012 | 833 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2266 | 0.070 |
Why?
|
Phlebography | 1 | 2006 | 333 | 0.060 |
Why?
|
Ovariectomy | 2 | 2019 | 661 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2214 | 0.060 |
Why?
|
beta Catenin | 1 | 2010 | 1059 | 0.060 |
Why?
|
Brain Neoplasms | 3 | 2017 | 8863 | 0.060 |
Why?
|
X Chromosome | 4 | 1995 | 814 | 0.060 |
Why?
|
Osteolysis | 1 | 2006 | 270 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2002 | 4320 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9648 | 0.060 |
Why?
|
Sulfonamides | 1 | 2013 | 1938 | 0.060 |
Why?
|
Thymoma | 1 | 2005 | 186 | 0.060 |
Why?
|
Models, Molecular | 1 | 2014 | 5456 | 0.060 |
Why?
|
Hospitals | 1 | 2017 | 3952 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2010 | 1257 | 0.060 |
Why?
|
Mice | 11 | 2024 | 81183 | 0.060 |
Why?
|
Molecular Structure | 1 | 2007 | 1899 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 3 | 2006 | 3143 | 0.050 |
Why?
|
Fetal Diseases | 1 | 2008 | 903 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3537 | 0.050 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 1993 | 279 | 0.050 |
Why?
|
Nonlinear Dynamics | 1 | 2005 | 502 | 0.050 |
Why?
|
Normetanephrine | 1 | 2021 | 26 | 0.050 |
Why?
|
Pancreatitis | 1 | 2009 | 1092 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8037 | 0.050 |
Why?
|
DNA, Recombinant | 1 | 2002 | 476 | 0.050 |
Why?
|
Veins | 1 | 2006 | 770 | 0.050 |
Why?
|
Killer Cells, Lymphokine-Activated | 3 | 1992 | 42 | 0.050 |
Why?
|
Risk Assessment | 3 | 2019 | 23338 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4217 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13102 | 0.050 |
Why?
|
Quinazolines | 1 | 2008 | 1356 | 0.050 |
Why?
|
Risk Factors | 6 | 2022 | 72290 | 0.050 |
Why?
|
Image Enhancement | 1 | 2013 | 2921 | 0.050 |
Why?
|
Aged | 6 | 2023 | 163280 | 0.050 |
Why?
|
Aneurysm, False | 1 | 2004 | 276 | 0.050 |
Why?
|
Weight Loss | 1 | 2013 | 2622 | 0.050 |
Why?
|
Remission Induction | 2 | 2018 | 2386 | 0.050 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 2 | 1998 | 29 | 0.050 |
Why?
|
Protein Binding | 1 | 2014 | 9386 | 0.050 |
Why?
|
Combined Modality Therapy | 4 | 2019 | 8642 | 0.050 |
Why?
|
Peptide Library | 1 | 2002 | 349 | 0.050 |
Why?
|
Animals | 15 | 2024 | 168757 | 0.050 |
Why?
|
Sclerosis | 1 | 2001 | 213 | 0.050 |
Why?
|
Chromogranins | 1 | 2021 | 160 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2969 | 0.050 |
Why?
|
Lymphocytes | 1 | 1989 | 2617 | 0.050 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2013 | 1344 | 0.050 |
Why?
|
Adenoids | 1 | 2020 | 33 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2013 | 5391 | 0.050 |
Why?
|
Cause of Death | 1 | 2011 | 3584 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2022 | 57776 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2009 | 1519 | 0.050 |
Why?
|
Palate, Soft | 1 | 2020 | 96 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2010 | 903 | 0.040 |
Why?
|
Protons | 1 | 2005 | 1127 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 2020 | 193 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3327 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2011 | 11366 | 0.040 |
Why?
|
Cell Communication | 2 | 1998 | 1621 | 0.040 |
Why?
|
Molecular Sequence Data | 5 | 2002 | 18111 | 0.040 |
Why?
|
Bacteriophages | 1 | 2002 | 356 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2013 | 3864 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2002 | 13815 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9981 | 0.040 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2004 | 574 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2022 | 502 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2016 | 15295 | 0.040 |
Why?
|
Adrenal Glands | 1 | 2021 | 546 | 0.040 |
Why?
|
Melanoma, Experimental | 1 | 2002 | 561 | 0.040 |
Why?
|
Pelvis | 1 | 2023 | 730 | 0.040 |
Why?
|
Crohn Disease | 1 | 2012 | 2303 | 0.040 |
Why?
|
Blood Glucose | 1 | 2013 | 6256 | 0.040 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2020 | 876 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 426 | 0.040 |
Why?
|
DNA Primers | 1 | 2002 | 2892 | 0.040 |
Why?
|
Expert Testimony | 1 | 2020 | 356 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 3 | 1996 | 1369 | 0.040 |
Why?
|
Blood Sedimentation | 1 | 2018 | 231 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2019 | 371 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2018 | 10943 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 1998 | 315 | 0.040 |
Why?
|
Radiography | 3 | 2005 | 7023 | 0.040 |
Why?
|
Tongue | 1 | 2020 | 406 | 0.040 |
Why?
|
Retreatment | 1 | 2019 | 610 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2002 | 2088 | 0.040 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1999 | 504 | 0.040 |
Why?
|
Parotid Gland | 1 | 2017 | 168 | 0.040 |
Why?
|
Dacarbazine | 2 | 2010 | 566 | 0.040 |
Why?
|
Radiology | 1 | 2010 | 2100 | 0.030 |
Why?
|
Glioma | 1 | 2011 | 3401 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.030 |
Why?
|
Neurofibromin 2 | 1 | 2017 | 267 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2023 | 906 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.030 |
Why?
|
Preoperative Care | 2 | 2019 | 2250 | 0.030 |
Why?
|
Medical Informatics Applications | 1 | 2017 | 186 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 196 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2004 | 1912 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1880 | 0.030 |
Why?
|
Middle Aged | 6 | 2023 | 213383 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2327 | 0.030 |
Why?
|
Eating | 1 | 2022 | 1536 | 0.030 |
Why?
|
Peripheral Vascular Diseases | 1 | 1998 | 550 | 0.030 |
Why?
|
Aza Compounds | 1 | 2015 | 32 | 0.030 |
Why?
|
Graft Occlusion, Vascular | 1 | 1998 | 549 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3251 | 0.030 |
Why?
|
Multigene Family | 1 | 1998 | 1102 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1998 | 881 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 1995 | 218 | 0.030 |
Why?
|
Precipitin Tests | 2 | 1998 | 829 | 0.030 |
Why?
|
Embolization, Therapeutic | 1 | 2004 | 1392 | 0.030 |
Why?
|
Radiology, Interventional | 1 | 1998 | 460 | 0.030 |
Why?
|
Survival Rate | 3 | 2016 | 12788 | 0.030 |
Why?
|
Arm | 1 | 2017 | 589 | 0.030 |
Why?
|
Static Electricity | 1 | 2015 | 267 | 0.030 |
Why?
|
Drug Evaluation | 3 | 1992 | 647 | 0.030 |
Why?
|
Executive Function | 1 | 2023 | 1364 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2727 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2013 | 19905 | 0.030 |
Why?
|
Base Sequence | 2 | 2002 | 12797 | 0.030 |
Why?
|
Microbial Viability | 1 | 2014 | 234 | 0.030 |
Why?
|
Models, Structural | 1 | 1993 | 361 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.030 |
Why?
|
Dipeptides | 1 | 2015 | 409 | 0.030 |
Why?
|
Dimerization | 1 | 2014 | 893 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3508 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2011 | 3616 | 0.030 |
Why?
|
Leg | 1 | 2017 | 1116 | 0.030 |
Why?
|
COS Cells | 1 | 2014 | 1161 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 1998 | 1423 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2004 | 3821 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2005 | 3297 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2011 | 3479 | 0.030 |
Why?
|
Cytokines | 2 | 1998 | 7322 | 0.030 |
Why?
|
Indazoles | 1 | 2013 | 289 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 379 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 1995 | 3129 | 0.030 |
Why?
|
Mycobacterium | 1 | 1993 | 249 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9734 | 0.020 |
Why?
|
Protein Engineering | 1 | 2015 | 540 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1094 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12354 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1998 | 1821 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1993 | 342 | 0.020 |
Why?
|
Human Body | 1 | 2011 | 39 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 2 | 2009 | 1695 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3557 | 0.020 |
Why?
|
Flow Cytometry | 2 | 1992 | 5974 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12745 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 1993 | 689 | 0.020 |
Why?
|
Burkitt Lymphoma | 1 | 1993 | 327 | 0.020 |
Why?
|
Glycemic Index | 1 | 2013 | 395 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2013 | 592 | 0.020 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2010 | 65 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1801 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1993 | 1454 | 0.020 |
Why?
|
Gestational Age | 2 | 2009 | 3493 | 0.020 |
Why?
|
Organ Specificity | 1 | 2015 | 2008 | 0.020 |
Why?
|
Polyhydramnios | 1 | 2009 | 41 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1998 | 1177 | 0.020 |
Why?
|
Vinblastine | 1 | 2011 | 502 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2013 | 462 | 0.020 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2002 | 2245 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2022 | 4554 | 0.020 |
Why?
|
Biotin | 1 | 1990 | 254 | 0.020 |
Why?
|
CHO Cells | 1 | 1992 | 1406 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 249 | 0.020 |
Why?
|
Pregnancy | 3 | 2023 | 29144 | 0.020 |
Why?
|
Binding, Competitive | 1 | 1990 | 1157 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 1005 | 0.020 |
Why?
|
Motion | 1 | 2013 | 798 | 0.020 |
Why?
|
Fetal Movement | 1 | 2008 | 21 | 0.020 |
Why?
|
Heat-Shock Proteins | 1 | 1993 | 822 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 1998 | 6386 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2013 | 650 | 0.020 |
Why?
|
Cricetinae | 1 | 1992 | 2472 | 0.020 |
Why?
|
Computer Simulation | 2 | 2012 | 6196 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3689 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2010 | 793 | 0.020 |
Why?
|
Carboplatin | 1 | 2011 | 801 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 906 | 0.020 |
Why?
|
Intra-Abdominal Fat | 1 | 2013 | 591 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3128 | 0.020 |
Why?
|
Perfusion | 1 | 2012 | 1360 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2029 | 0.020 |
Why?
|
Histocompatibility Antigens | 1 | 1989 | 471 | 0.020 |
Why?
|
Camptothecin | 1 | 2010 | 576 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1997 | 6622 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 1998 | 3036 | 0.020 |
Why?
|
T-Lymphocytes | 3 | 1994 | 10180 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9687 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14722 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1775 | 0.020 |
Why?
|
Receptors, Fc | 1 | 1990 | 541 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5615 | 0.020 |
Why?
|
Models, Statistical | 2 | 2012 | 5102 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2012 | 1254 | 0.020 |
Why?
|
Hepatectomy | 1 | 2010 | 550 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
Epitopes | 1 | 1993 | 2571 | 0.020 |
Why?
|
Spinal Cord Compression | 1 | 2008 | 235 | 0.020 |
Why?
|
Mutation | 3 | 2017 | 29786 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2009 | 600 | 0.020 |
Why?
|
Uncertainty | 1 | 2011 | 734 | 0.020 |
Why?
|
Cognition | 1 | 2023 | 6770 | 0.020 |
Why?
|
Necrosis | 1 | 2010 | 1643 | 0.020 |
Why?
|
Drug Eruptions | 1 | 2008 | 297 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4215 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17446 | 0.020 |
Why?
|
Rhabdomyosarcoma | 1 | 2008 | 382 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2013 | 2015 | 0.020 |
Why?
|
Cell Line | 3 | 1997 | 15997 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2454 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2016 | 2119 | 0.020 |
Why?
|
Birth Weight | 1 | 2013 | 2069 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4933 | 0.020 |
Why?
|
Sex Distribution | 1 | 2010 | 2297 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1989 | 1588 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3703 | 0.020 |
Why?
|
Morbidity | 1 | 2010 | 1769 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18029 | 0.020 |
Why?
|
Chronic Disease | 1 | 1999 | 9146 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 53288 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4851 | 0.020 |
Why?
|
Area Under Curve | 1 | 2008 | 1654 | 0.010 |
Why?
|
Age Distribution | 1 | 2010 | 2902 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3887 | 0.010 |
Why?
|
Adiposity | 1 | 2013 | 1807 | 0.010 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2008 | 501 | 0.010 |
Why?
|
Immunotherapy | 2 | 1989 | 4445 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2008 | 1641 | 0.010 |
Why?
|
Osteosarcoma | 1 | 2008 | 881 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1989 | 1607 | 0.010 |
Why?
|
Cartilage | 1 | 2006 | 818 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2009 | 1416 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1998 | 7880 | 0.010 |
Why?
|
Diarrhea | 1 | 2008 | 1348 | 0.010 |
Why?
|
Apoptosis | 1 | 1997 | 9727 | 0.010 |
Why?
|
Delivery, Obstetric | 1 | 2008 | 906 | 0.010 |
Why?
|
Abscess | 1 | 2004 | 607 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2942 | 0.010 |
Why?
|
Nephrectomy | 1 | 2006 | 1050 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8663 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2002 | 0.010 |
Why?
|
Forecasting | 1 | 1989 | 2951 | 0.010 |
Why?
|
Blood Vessel Prosthesis | 1 | 2004 | 933 | 0.010 |
Why?
|
Genetic Linkage | 2 | 1995 | 2421 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12026 | 0.010 |
Why?
|
Osteogenesis | 1 | 2006 | 1299 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2728 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.010 |
Why?
|
Kinetics | 2 | 1997 | 6473 | 0.010 |
Why?
|
Prosthesis-Related Infections | 1 | 2004 | 538 | 0.010 |
Why?
|
Glycosylphosphatidylinositols | 1 | 1998 | 94 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23403 | 0.010 |
Why?
|
Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
Cell Division | 2 | 1996 | 4568 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5985 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6756 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12245 | 0.010 |
Why?
|
Cell Aggregation | 1 | 1997 | 244 | 0.010 |
Why?
|
GPI-Linked Proteins | 1 | 1998 | 434 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1997 | 242 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 1997 | 216 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1809 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Disease Progression | 1 | 2013 | 13284 | 0.010 |
Why?
|
Ionomycin | 1 | 1996 | 109 | 0.010 |
Why?
|
Ionophores | 1 | 1996 | 108 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18370 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2004 | 1400 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13408 | 0.010 |
Why?
|
Incidence | 1 | 2013 | 20947 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1996 | 307 | 0.010 |
Why?
|
Dosage Compensation, Genetic | 1 | 1995 | 211 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1996 | 537 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1997 | 2050 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 7913 | 0.010 |
Why?
|
Interleukin-12 | 1 | 1996 | 579 | 0.010 |
Why?
|
Models, Immunological | 1 | 1996 | 527 | 0.010 |
Why?
|
Chaperonin 60 | 1 | 1993 | 103 | 0.010 |
Why?
|
Tryptophan Oxygenase | 1 | 1992 | 19 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 1996 | 4420 | 0.010 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 1992 | 27 | 0.010 |
Why?
|
Interleukin-4 | 1 | 1996 | 1147 | 0.010 |
Why?
|
Interleukin-1 | 1 | 1996 | 1263 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1992 | 315 | 0.010 |
Why?
|
Cross Reactions | 1 | 1993 | 841 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20822 | 0.010 |
Why?
|
Granulocytes | 1 | 1992 | 548 | 0.010 |
Why?
|
Palliative Care | 1 | 2004 | 3493 | 0.010 |
Why?
|
Protein Conformation | 1 | 1995 | 4011 | 0.000 |
Why?
|
Leukocytes | 1 | 1996 | 2043 | 0.000 |
Why?
|
Transfection | 1 | 1995 | 5892 | 0.000 |
Why?
|
Immunotherapy, Adoptive | 1 | 1996 | 1270 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2005 | 21827 | 0.000 |
Why?
|
Diet | 1 | 2005 | 7939 | 0.000 |
Why?
|
Rabbits | 1 | 1993 | 4894 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 13033 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1992 | 3206 | 0.000 |
Why?
|
Monocytes | 1 | 1992 | 2596 | 0.000 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1990 | 2540 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1996 | 19229 | 0.000 |
Why?
|
Bacterial Proteins | 1 | 1993 | 3848 | 0.000 |
Why?
|
Phenotype | 1 | 1990 | 16365 | 0.000 |
Why?
|